A new study shows that people are more likely to buy prescription drugs if they can get the best price and a better offer from their pharmacist, a phenomenon called “price discrimination”.
This is often a bad sign.
It means they are choosing less expensive drugs, says Andrew Burchfield, a pharmacist and assistant professor of pharmacy at the University of Washington in Seattle.
“When a person is being treated for cancer, and they have a choice of what to get, they’ll buy the cheapest drug available,” says Burchfields.
But the study shows people are equally likely to choose cheaper, more generic drugs.
This can be because they think they can find cheaper generic drugs at their local pharmacy, or because they are paying less for the drug.
“I don’t think price discrimination is always a bad thing,” says Robert Berenson, an economist at the American Association of Retired Persons.
But it’s a sign of things to come.
The study is the latest to show that people tend to shop more when they can see a better deal than they do from their own doctor.
It is also a new way to track prices and compare prices across health markets, says Berensmith, who has been studying pharmacy prices in the US for about 20 years.
This is especially true in the United States, where prices are typically lower than those in Europe and other parts of the world.
But he says it is also true of other countries.
Price discrimination has been linked to higher costs, says Dr Michael Kranish, a professor of medicine at Harvard Medical School in Boston, Massachusetts.
“If a patient is able to get a better price and get an offer that they think is better than the one they got at their doctor, then they are more willing to go out and buy a drug that they would not normally,” he says.
It can also be a sign that a drug is more expensive than what it costs elsewhere, which can lead to more prescription drug spending.
“We see price discrimination pretty consistently in the pharmaceutical industry,” says Dr Mark Karponis, a pharmacologist at the Cleveland Clinic in Ohio.
“It happens when the company or pharmacist is charging the same price as other pharmacies.
“The price discrimination has a lot to do with how many people are paying for the same drug, says Karponi. “
“So if you’re paying $1,000 for an antibiotic, it’s likely that the price differential is only $500. “
If you’re only paying $50 for an anti-inflammatory, it is more likely that you’ll pay $50,” he explains. “
So if you’re paying $1,000 for an antibiotic, it’s likely that the price differential is only $500.
If you’re only paying $50 for an anti-inflammatory, it is more likely that you’ll pay $50,” he explains.
But there is also another reason why people are shopping more, says Gail Hausman, an assistant professor at the Kellogg School of Management in Iowa City, Iowa.
“In a lot of ways, it reflects how much money is being spent,” she says.
“Price discrimination affects all the costs of prescription drugs.
It also affects the quality of life.”
The study, published in the journal Health Economics, looked at prices at four drug stores in the Chicago area, and also at online drugstores.
The pharmacy prices were based on the generic drug cost and the price of the branded drug.
The prices were then averaged across the four stores, with the prices for the branded drugs averaged separately.
This gave a broader picture of how much people are spending.
The researchers then looked at how much the average price of a generic drug had gone up over the past five years.
In that period, generic drug prices rose by almost 20 per cent, while brand drugs rose by less than 10 per cent.
The biggest increases in price were seen for generic drugs and branded drugs.
But both drugs and brand drugs were still cheaper than they were five years ago.
“The real story here is that prices are going up,” says Hausmann.
“They’re going up at the same time prices for branded drugs are going down.
The problem is, we don’t have the data to look at this from the perspective of how many times a month a brand drug has been sold at the pharmacy or online.”
Drug prices are one of the main drivers of healthcare spending, says Hsu.
“Every dollar spent on healthcare costs money for the country.
The pharmaceutical industry is the single biggest driver of health care spending.”
Hausmans findings are important because they can help explain why the cost of drugs like generic drugs has risen over the years, and may not be sustainable, says Robert Karponis, a pharmaceutical industry consultant in Washington DC.
The reason, Karponyis says, is that the cost-of-care has become a lot more complicated over the last decade.